Article
Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials.
Expert opinion on biological therapy - 1 Feb 2008
Asensio Jesus A Gonzalo, Arbués Ainhoa, Pérez Esther, Gicquel Brigitte, Martin Carlos
Abstract excerpt
Bacillus Calmette-Guérin (BCG) is the only preventive treatment for tuberculosis in humans, but this live vaccine confers variable protection against pulmonary tuberculosis in adults. Advances in the understanding of Mycobacterium tuberculosis immunopathogenesis have renewed hopes of developing new prophylactic vaccines conferring better protection than BCG. The authors describe here state-of-the-art attenuated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
